Back to search

Article

Metformin decreases <i>Cyp26a1</i> to prevent hepatocarcinogenesis through down- regulating CD8 <sup>+</sup> T cells

2022-04-28

Abstract excerpt

Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, which limits the selectivity of prevention and treatment. Preclinical and clinical studies suggested that in patients with diabetes, prolonged use of metformin, the AMPK activator, was associated with a reduction of HCC incidence. This association promotes us to investigate the possible functions and mechanisms of metformin in HCC without diabetes ba...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1156a5b-434e-5280-abb8-ff701dfa04a3
DOI
10.1101/2022.04.27.489721
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin decreases <i>Cyp26a1</i> to prevent hepatocarcinogenesis through down- regulating CD8 <sup>+</sup> T cellsDOI 10.1101/2022.04.27.489721
Select a neighboring publication to make it the new centre.